Main menu

Nanopore sequencing solutions for cell and gene therapies


2-page image of the biopharma brochure

Overview

Next-generation sequencing (NGS) is an essential tool across the drug development value chain. However, legacy NGS technologies require fragmentation and amplification steps, erasing critical sample information. Discover how Oxford Nanopore Technologies sequencing overcomes these limitations with direct, PCR-free workflows to reveal the true biology of your samples.

In this brochure, find out how nanopore sequencing can be applied in the development of cell, gene, and RNA therapies to provide the data you need to develop better and safer drugs, whilst reducing risk .

入门指南

购买 MinION 启动包 Nanopore 商城 测序服务提供商 全球代理商

联系我们

Intellectual property Cookie policy Corporate reporting Privacy policy Terms & conditions Accessibility

关于 Oxford Nanopore

Contact us 领导团队 媒体资源和联系方式 投资者 在 Oxford Nanopore 工作 BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Chinese flag